Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene

被引:137
作者
Yavuz, AS
Lipsky, PE
Yavuz, S
Metcalfe, DD
Akin, C
机构
[1] NIAID, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA
[2] NIAMS, Autoimmun Branch, Bethesda, MD USA
关键词
D O I
10.1182/blood-2002-01-0203
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mast cells are derived from multipotential hernatopoietic progenitors and are clonally increased in systemic mastocytosis, a disease associated with point mutations of codon 816 (most commonly Asp816Val) of c-kit. To study the lineage relationship and the extent of expansion of cells derived from the mutated clone, we examined the occurrence of the Asp816Val c-kit mutation in genomic DNA of individual sorted peripheral blood T cells, B cells, and monocytes in patients with indolent systemic mastocytosis. The mutation was detected in varying frequencies in the genomic DNA of individual B cells and monocytes and bone marrow mast cells in patients with extensive disease. In B cells, the immunoglobulin repertoire was polyclonal, indicating that the mutation occurred before V-H/(D)/J(H) recombination. These results show that mastocytosis is a disorder of a pluripotential hematopoietic progenitor cell that gives rise to B cells and monocytes in addition to mast cells and that the affected clone shows variable expansion in these lineages in the peripheral blood of patients with systemic mastocytosis. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:661 / 665
页数:5
相关论文
共 17 条
  • [1] Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis
    Akin, C
    Kirshenbaum, AS
    Semere, T
    Worobec, AS
    Scott, LM
    Metcalfe, DD
    [J]. EXPERIMENTAL HEMATOLOGY, 2000, 28 (02) : 140 - 147
  • [2] Soluble stem cell factor receptor (CD117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathology
    Akin, C
    Schwartz, LB
    Kitoh, T
    Obayashi, H
    Worobec, AS
    Scott, LM
    Metcalfe, DD
    [J]. BLOOD, 2000, 96 (04) : 1267 - 1273
  • [3] Slowly progressive systemic mastocytosis with high mast-cell burden and no evidence of a non-mast-cell hematologic disorder: an example of a smoldering case?
    Akin, C
    Scott, LM
    Metcalfe, DD
    [J]. LEUKEMIA RESEARCH, 2001, 25 (07) : 635 - 638
  • [4] BREZINSCHEK HP, 1995, J IMMUNOL, V155, P190
  • [5] Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis:: A possible explanation for divergent clinical behavior
    Büttner, C
    Henz, BM
    Welker, P
    Sepp, NT
    Grabbe, J
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (06) : 1227 - 1231
  • [6] IDENTIFICATION OF MUTATIONS IN THE CODING SEQUENCE OF THE PROTOONCOGENE C-KIT IN A HUMAN MAST-CELL LEUKEMIA-CELL LINE CAUSING LIGAND-INDEPENDENT ACTIVATION OF C-KIT PRODUCT
    FURITSU, T
    TSUJIMURA, T
    TONO, T
    IKEDA, H
    KITAYAMA, H
    KOSHIMIZU, U
    SUGAHARA, H
    BUTTERFIELD, JH
    ASHMAN, LK
    KANAYAMA, Y
    MATSUZAWA, Y
    KITAMURA, Y
    KANAKURA, Y
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (04) : 1736 - 1744
  • [7] Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
    Hirota, S
    Isozaki, K
    Moriyama, Y
    Hashimoto, K
    Nishida, T
    Ishiguro, S
    Kawano, K
    Hanada, M
    Kurata, A
    Takeda, M
    Tunio, GM
    Matsuzawa, Y
    Kanakura, Y
    Shinomura, Y
    Kitamura, Y
    [J]. SCIENCE, 1998, 279 (5350) : 577 - 580
  • [8] A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val
    Jordan, JH
    Fritsche-Polanz, R
    Sperr, WR
    Mitterbauer, G
    Födinger, M
    Schernthaner, GH
    Bankl, HC
    Gebhart, W
    Chott, A
    Lechner, K
    Valent, P
    [J]. LEUKEMIA RESEARCH, 2001, 25 (07) : 627 - 634
  • [9] Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis
    Longley, BJ
    Metcalfe, DD
    Tharp, M
    Wang, XM
    Tyrrell, L
    Lu, SZ
    Heitjan, D
    Ma, YS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (04) : 1609 - 1614
  • [10] Nagata H, 1996, EXP CLIN IMMUNOGENET, V13, P210